Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Vertex Pharmaceuticals Incorporated reports strong financial results for Q4 and full year 2024

February 12, 2025
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced its fourth quarter and full year 2024 financial results, exceeding expectations with record-breaking revenue of $11.02 billion. The company's revenue growth was driven by the FDA approval of two key drugs, which have significantly contributed to the company's success.
Vertex Pharmaceuticals' stock price has seen a significant increase, and experts from Stocks Prognosis recommend considering buying the company's shares, as they predict further growth in the coming months. The intrinsic value of Vertex Pharmaceuticals is potentially 50% above its current share price. Investors who are looking for a promising opportunity in the pharmaceutical industry should consult with the professionals at Stocks Prognosis for a reliable forecast of the company's stock movement.
If you want to leave a comment, then you need Login or Register





Other data for VRTX

Related data

VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecast Price Target, Generating 8.59% Profit  ~1 min.

On May 7, 2024, QuantWave issued a short signal for VERTEX PHARMACEUTICALS INCORPORATED with a price target of 374.98 $....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target with 15.82% Profit, Validates QuantWave's Forecasting Accuracy  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the price target forecast set by QuantWave, a notable milestone that not only indicates the platform's forecasting accuracy but also presents a lucrative opportunity for investors. The forecast signal was generated on June 2, 2025, when the stock was trading at $445.43, with a predicted short direction. Fast forward to August 5, 2025, th...


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Successfully Hits Price Target Forecast with 16.01% Profit: A Triumph for QuantWave's Analytics  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecasted price target, as predicted by QuantWave's automated forecasting platform on 2025-06-03....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target with 8.54% Profit Margin  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved its price target forecast, generating an 8.54% profit margin for investors....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecast Target with 7.36% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) stock successfully achieved the price target forecast set by QuantWave, a leading automated forecasting platform, with a profitable outcome of 7.36%....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Reaches Price Target Forecast with 8.02% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock successfully reached the price target forecast set by QuantWave on July 9, 2025....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Target with 8.37% Profit: A Success Story for QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecast price target set by QuantWave, resulting in a profit of 8.37% for investors who followed the long prediction signal....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecasted Price Target with 8.64% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) stock successfully reached the forecasted price target set by QuantWave on 2025-06-20, with a predicted long direction. The stock was valued at 440....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits QuantWave Forecast Target with 7.59% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the forecast price target set by QuantWave on June 30, 2025....


VRTXJuly 9, 2025Vertex Pharmaceuticals Incorporated Hits Price Target Forecast with 7.44% Profit  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 7.44%....


VRTXJanuary 12, 2025Vertex Pharmaceuticals Incorporated Faces Setbacks in Clinical Trials  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares experienced a slide recently due to setbacks in its clinical trials....


VRTXJanuary 28, 2025Earnings Preview: Vertex Pharmaceuticals VRTX Q4 Earnings Expected to Decline  ~2 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is set to release its fourth-quarter earnings report on [date]. Analysts predict a decline in earnings compared to the same period last year....


VRTXJanuary 1, 2025New Developments and Promising Future for Vertex Pharmaceuticals Inc. (VRTX)  ~2 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been making headlines recently with its groundbreaking innovations in the field of biotechnology....


VRTXJanuary 29, 2025Brighton Jones LLC Increases Stake in Vertex Pharmaceuticals VRTX  ~1 min.

Brighton Jones LLC, a prominent investment firm, has recently revealed that it has increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)....


VRTXJanuary 22, 2025Vertex Pharmaceuticals Incorporated VRTX Leading the Trend: What You Should Know  ~2 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been making waves in the stock market recently, attracting the attention of investors....